GSK plc: decline losing momentum, but technical picture stays negative
GSK plc is in its 5th week of a sell signal: this week the stock bounced 3% with buyers dominant, but the MACD histogram remains negative and CMF has not yet reversed. An evolution to watch carefully.
Glencore: coverage complete, runner on the Inversion Point
Glencore is at week 37 of a trade that has hit all 3 targets of our model. The 40% runner continues with a trailing stop at +77% from entry, and this week the stock rebounded 3.9% amid distribution volumes.
iShares STOXX Europe 600 Basic Resources: 2 targets hit, next trim window at week 10
Eight weeks into the buy on the European basic resources sector ETF: 2 of the 3 model targets already hit, trade up 5.7% and next management window at week 10. The outlook remains bullish but early weakness signals are emerging.
EXV4 — five weeks in, the decline hasn't confirmed
Five weeks into the sell signal on iShares STOXX Europe 600 Health Care, the decline has never truly confirmed: three sideways weeks, positive CMF and a double bottom in the 107 area. The picture calls for a wait-and-see stance.
iShares Tech Europe: 2 targets hit, stop above breakeven
At week 7 of the buy signal on the European tech ETF, 2 of the 3 statistical targets of our model have already been hit. The trade is up 14%, stop well above breakeven, and next management window at week 8.
iShares Telecom EU: 2 targets hit, but the weekly close speaks for itself
At week 8 of a buy with 2 of the 3 model targets already hit, the confirmation week closed bearish. The signal is fading: IQS at 56, strength at 32, ranked 58th of 65. The exit window is open.